21-12-2017 | Type 1 diabetes | Clinical trial summary slides | Gallery
Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial
This slide set presents trial findings showing that patients with well-controlled type 1 diabetes who undergo flash glucose testing achieve a greater reduction in the time spent in hypoglycemia over 6 months than those who carry out standard self-monitoring.
Read the full-text article here
Funded by an educational grant from Abbott Diabetes Care
There was a 38% reduction in time in hypoglycaemia in the intervention group
Time below all hypoglycaemic thresholds as well as time spent in hyperglycaemia were significantly improved in the intervention group compared with controls
Number of hypoglycaemic episodes were significantly improved in the intervention group compared with controls